Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

被引：0
|
作者：
Cicin, Irfan
Gumus, Mahmut
Uncu, Dogan
Ozkan, Metin
Kilickap, Saadettin
Elkiran, Tamer E.
Isikdogan, Abdurrahman
Karaoglu, Aziz
Oksuzoglu, Berna
Ozdemir, Feyyaz
Turna, Hande
Kara, Oguz
Ozyilkan, Ozgur
Guducu, Merve
Erdogan, Alper
Uslu, Ruchan
机构：
[1] Trakya Univ, Dept Med Oncol, Fac Med, Edirne, Turkey
[2] Istanbul Medeniyet Univ, Dept Med Oncol, Fac Med, Istanbul, Turkey
[3] Ankara Numune Training & Res Hosp, Dept Med Oncol, Ankara, Turkey
[4] Fac Med, Dept Med Oncol, Kayseri, Turkey
[5] Hacettepe Univ, Dept Med Oncol, Ankara, Turkey
[6] Malatya Inonu Univ, Fac Med, Kayseri, Turkey
[7] Diyarbakir Dicle Univ, Fac Med, Diyarbakir, Turkey
[8] Dokuz Eylul Univ, Balcova, Turkey
[9] Dr AY Ankara Oncol Training & Res Hosp, Dept Med Oncol, Ankara, Turkey
[10] Karadniz Tech Univ, Fac Med, Trabzon, Turkey
[11] Istanbul Univ, Cerrahpasa Fac Med, Dept Oncol, Istanbul, Turkey
[12] Adana Cukurova Univ, Fac Med, Adana, Turkey
[13] Baskent Univ, Dept Med Oncol, Fac Med, Adana, Turkey
[14] Uniq Istanbul, Istanbul, Turkey
[15] Roche Pharmaceut, Istanbul, Turkey
[16] Ege Univ, Izmir, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15055
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Demographics and clinical characteristics of metastatic colorectal cancer patients treated with a biosimilar to bevacizumab
    Rhodes, W.
    Accortt, N.
    DeClue, R.
    Jin, R.
    Sandschafer, D.
    Wertz, D.
    Patel, K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S156 - S156
  • [2] Bevacizumab in elderly patients with metastatic colorectal cancer
    Sclafani, Francesco
    Cunningham, David
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 78 - 88
  • [3] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Cherciu, Nelly
    Petria, Cristina
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
  • [4] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Benedik, Jernej
    Volk, Neva
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [5] Bevacizumab safety in Japanese patients with colorectal cancer
    Hatake, Kiyohiko
    Doi, Toshihiko
    Uetake, Hiroyuki
    Takahashi, Yoichiro
    Ishihara, Yumi
    Shirao, Kuniaki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 234 - 240
  • [6] Turkish cancer patients' preference for information and communication technologies
    Ildes, E.
    Eser, A. Karaaslan
    Gokdag, S. T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [7] Bevacizumab in colorectal cancer
    Sharieff, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (16): : 1690 - 1690
  • [8] Management of FOLFOXIRI and Bevacizumab therapy for colorectal cancer patients
    Kagawa, Yoshinori
    Naito, Atsushi
    Kawai, Kenji
    Mori, Ryota
    Sakamoto, Takuya
    Murakami, Kohei
    Katsura, Yoshiteru
    Omura, Yoshiaki
    Masuzawa, Toru
    Takeno, Atsushi
    Takeda, Yutaka
    Kato, Takeshi
    Murata, Kohei
    [J]. CANCER SCIENCE, 2018, 109 : 673 - 673
  • [9] Tumor location in patients with colorectal cancer treated with bevacizumab
    Teresa, Delgado Urena Ma
    Beatriz, Gonzalez-Astorga
    Alvarez Marta, Legeren
    Patricia Maria, Moreno Raya
    Cebrian Irene, Gonzalez
    Montosa Fernando, Galvez
    Carlos Jose, Rodriguez Gonzalez
    Vargas Marisol, Yelamos
    Jose Miguel, Jurado Garcia
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Bevacizumab in older patients with advanced colorectal or breast cancer
    Aprile, Giuseppe
    Ferrari, Laura
    Fontanella, Caterina
    Puglisi, Fabio
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (01) : 41 - 54
12345